Searched over 200M research papers
10 papers analyzed
These studies suggest cerebrovascular disease is caused by ischemic brain injury, impaired brain perfusion, central nervous system infections, genetic factors, and non-structural vascular dysfunction.
20 papers analyzed
Cerebrovascular disease (CVD) encompasses a range of conditions that affect the blood vessels and blood supply to the brain, leading to ischemia (lack of blood flow) or hemorrhage (bleeding). These conditions are significant contributors to disability and mortality worldwide, often resulting in cognitive impairment and dementia .
Ischemic injury, caused by reduced blood flow to the brain, is a primary mechanism leading to cognitive impairment in CVD. This can result from arteriosclerosis, multi-infarct dementia, and other vascular cognitive impairments (VCI). The destruction of brain tissue due to ischemic injury, particularly in large volumes, has been linked to arteriosclerotic dementia.
CVD can also arise as a complication of central nervous system (CNS) infections. Infections can lead to vasculitis, vasospasm, thrombosis, or a hypercoagulable state, all of which can cause cerebral infarction. These vascular complications often result in severe neurological outcomes, including stroke and death.
Aging and Alzheimer's disease (AD) share common risk factors and neuropathological features with CVD. Structural vascular disease and non-structural vascular dysfunction contribute to cerebral hypoperfusion in AD, exacerbating cognitive decline. The vasoconstrictor endothelin-1 (EDN1) has been identified as a significant mediator in this process .
Genetic predisposition plays a crucial role in the development of CVD. Variants in genes related to lipid metabolism, such as the PCSK9 gene, have been implicated in ischemic stroke and atherosclerosis. These genetic factors interact with environmental and lifestyle factors, contributing to individual susceptibility to CVD.
CVD is a common cause of secondary movement disorders, which can manifest as hypokinetic or hyperkinetic movements following ischemic or hemorrhagic strokes. These disorders may also result from vascular malformations and other cerebrovascular abnormalities.
Microvascular pathology, including reduced blood supply and disrupted microvascular integrity, is a significant contributor to cognitive decline in aging and AD. Vasoconstriction and subsequent cerebral hypoperfusion can lead to neuronal damage and impaired cognitive function.
CVD includes a variety of neuropathological changes, such as ischemia and hemorrhage, which affect brain function. These changes are critical in understanding the mechanisms leading to brain damage and developing therapeutic strategies.
Cerebrovascular disease is a multifaceted condition with various causes, including ischemic injury, infections, aging, genetic factors, and microvascular pathology. Understanding these mechanisms is crucial for developing effective prevention and treatment strategies to mitigate the impact of CVD on cognitive function and overall brain health.
Most relevant research papers on this topic